NAPOLETANO, Chiara
 Distribuzione geografica
Continente #
NA - Nord America 3.790
EU - Europa 1.632
AS - Asia 494
AF - Africa 59
SA - Sud America 38
OC - Oceania 1
Totale 6.014
Nazione #
US - Stati Uniti d'America 3.761
IT - Italia 824
SE - Svezia 257
IN - India 217
CN - Cina 129
FI - Finlandia 123
IE - Irlanda 109
SG - Singapore 98
DE - Germania 90
UA - Ucraina 69
AR - Argentina 34
BG - Bulgaria 32
GB - Regno Unito 31
EG - Egitto 30
CA - Canada 27
FR - Francia 21
TG - Togo 20
RO - Romania 19
HK - Hong Kong 17
AT - Austria 15
IR - Iran 13
CH - Svizzera 12
KR - Corea 8
BE - Belgio 6
RU - Federazione Russa 6
ZA - Sudafrica 6
PL - Polonia 5
TW - Taiwan 4
CO - Colombia 3
DK - Danimarca 3
MA - Marocco 2
MK - Macedonia 2
MX - Messico 2
NL - Olanda 2
NO - Norvegia 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BR - Brasile 1
ES - Italia 1
GR - Grecia 1
JP - Giappone 1
KH - Cambogia 1
KZ - Kazakistan 1
MV - Maldive 1
MY - Malesia 1
PK - Pakistan 1
PT - Portogallo 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
Totale 6.014
Città #
Fairfield 638
Rome 461
Chandler 304
Woodbridge 296
Ashburn 290
Seattle 270
Houston 215
Cambridge 212
Wilmington 188
Ann Arbor 140
Dublin 109
Princeton 96
Plano 79
Dearborn 77
Beijing 74
New York 71
San Paolo di Civitate 62
Lawrence 53
Helsinki 51
Boston 47
San Diego 44
Fremont 41
Milan 41
Millbury 35
Sofia 32
Singapore 30
Damanhur 29
Jacksonville 26
Andover 24
Federal 22
Lomé 20
Bremen 18
Hong Kong 17
Norwalk 15
Toronto 15
Boardman 13
Des Moines 13
Falls Church 13
Indore 11
San Mateo 11
Vienna 11
Salt Lake City 8
Hefei 7
Ottawa 7
Phoenix 7
Putignano 7
Redwood City 7
Shanghai 7
Southend 7
Brussels 6
Guangzhou 5
Palermo 5
Pomezia 5
San Isidro 5
Turin 5
Casatenovo 4
Ercolano 4
Florence 4
Kunming 4
Leawood 4
Livorno 4
London 4
Los Angeles 4
Mannheim 4
Nanjing 4
Washington 4
Zanjan 4
Baotou 3
Bengaluru 3
Birmingham 3
Buffalo 3
Bühl 3
Chiesina Uzzanese 3
Dongjak-gu 3
Germiston 3
Gunzenhausen 3
Kilburn 3
Lucknow 3
Modena 3
Monte Grande 3
Sacramento 3
Somerville 3
Taipei 3
Vaas 3
Velletri 3
Wroclaw 3
Anguillara 2
Auburn Hills 2
Bologna 2
Bonn 2
Boulogne Sur Mer 2
Brindisi 2
Buenos Aires 2
Busto Arsizio 2
Cappelle sul Tavo 2
Cascina 2
Catania 2
Council Bluffs 2
Grafing 2
Grezzana 2
Totale 4.435
Nome #
TK inhibitor pazopanib primes DCs by downregulation of the β-catenin pathway 149
The macrophage Galactose-type C-type Lectin (MGL) modulates regulatory T cell functions 134
Circulating CD137 + T cells correlate with improved response to anti-PD1 immunotherapy in cancer patients 133
Bevacizumab-based chemotherapy triggers immunological effects in responding multi-treated recurrent ovarian cancer patients by favoring the recruitment of effector t cell subsets 118
The sexist behaviour of immune checkpoint inhibitors in cancer therapy? 116
The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinoma 115
Profiles of cancer stem cell subpopulations in cholangiocarcinomas 114
Transplantation of stem/progenitor cells isolated from human fetal biliary tree into two patients with advanced liver cirrhosis 110
Triple peptide vaccination as consolidation treatment in women affected by ovarian and breast cancer: clinical and immunological data of a phase I/II clinical trial 110
Cross-talk between microbiota and immune fitness to steer and control response to anti PD-1/PDL-1 treatment 108
Discovery of chemotherapy-associated ovarian cancer antigens by interrogating memory T cells 107
Cardiosphere conditioned media influence the plasticity of human mediastinal adipose tissue-derived mesenchymal stem cells 106
Tumor associated MUC1 carried by microvesicles is cross-processed by dendritic cells generating CD8+ T cell response 104
Evidence for multipotent endodermal stem/progenitor cell populations in human gallbladder 101
Anisakis pegreffii impacts differentiation and function of human dendritic cells 98
Tumor Associated Tn-MUC1 Glycoform is Internalized through the Macrophage Galactose-type C-type Lectin and delivered to the HLA Class I and II Compartments in Dendritic Cells. 96
MGL receptor and immunity: when the ligand can make the difference 90
The prognostic impact of cancer stem-like cell biomarker aldehyde dehydrogenase-1 (ALDH1) in ovarian cancer. A meta-analysis 88
Tumor-derived microvesicles modulate antigen cross-processing via reactive oxygen species-mediated alkalinization of phagosomal compartment in dendritic cells 86
Suitability of Human Tenon's Fibroblasts as Feeder Cells for Culturing Human Limbal Epithelial Stem Cells 85
Transplantation of human fetal biliary tree stem/progenitor cells into two patients with advanced liver cirrhosis. 83
Immune effects of trastuzumab. 83
Immunological and clinical impact of cancer stem cells in vulvar cancer: role of CD133/CD24/ABCG2-Expressing Cells 83
Immune effects of CDK4/6 inhibitors in patients with HR+/HER2− metastatic breast cancer: relief from immunosuppression is associated with clinical response 81
Past, present and future strategies of immunotherapy in gynecological malignancies 78
Microvesicle cargo of tumor-associated MUC1 to dendritic cells allows cross-presentation and specific carbohydrate processing. 77
A standardized laboratory and surgical method for in vitro culture isolation and expansion of primary human Tenon's fibroblasts 75
Tumor derived Microvesicles enhance cross-processing ability of clinical grade Dendritic Cells 75
Preliminary results of a triple peptide escalating dose vaccination phase I/II clinical trial as consolidation treatment in women affected by ovarian cancer 74
Cancer testis antigen expression in primary and recurrent vulvar cancer: Association with prognostic factors 73
Current knowledge and open issues regarding Bevacizumab in gynaecological neoplasms 72
Death from Metastatic Donor-Derived Ovarian Cancer in a Male Kidney Transplant Recipient 71
Complete remission of ovarian cancer induced intractable malignant ascites with intraperitoneal bevacizumab. Immunological observations and a literature review 71
Ovarian cancer cytoreduction induces changes in T cell population subsets reducing immunosuppression 70
Multiple Tumor Associated Peptide Vaccination As Consolidation Treatment In Women Affected by Breast and Ovarian Cancer 69
Optimization of the isolation and expansion method of human mediastinal–adipose tissue derived mesenchymal stem cells with virally inactivated GMP-grade platelet lysate 68
The role of soluble LAG3 and soluble immune checkpoints profile in advanced head and neck cancer: a pilot study 66
A comparative analysis of serum and serum-free media for generation of clinical grade DCs 65
GALLBLADDER IS A HIGHLY AVAILABLE SOURCE OF STEM CELLS WITH MULTIPLE ENDODERMIC MATURE FATES POTENTIALITY 65
null 64
Immunohistochemical characterization of immune infiltrate in tumor microenvironment of glioblastoma 63
Distinct pathways of antigen processing of MUC1 tumor-associated glycoprotein in dendritic cells (DCs) 62
null 62
Immune-related toxicity and soluble profile in patients affected by solid tumors: a network approach 60
null 60
Exploratory pilot study of circulating biomarkers in metastatic renal cell carcinoma 60
Metformin exerts anti-cancerogenic effects and reverses epithelial-to-mesenchymal transition trait in primary human intrahepatic cholangiocarcinoma cells 59
Immunology of Gynecologic Neoplasms: Analysis of the Prognostic Significance of the Immune Status 58
Cells with Characteristics of Cancer Stem/Progenitor Cells Express the CD133 Antigen in Human Endometrial Tumors 58
HUMAN CHOLANGIOCARCINOMA (CCA) AND CCA CANCER STEM CELLS (CSCS) ARE HIGHLY SENSITIVE TO THE ANTIPROLIFERATIVE EFFECTS OF PI3-KINASE INHIBITORS 57
HPV induced triple neoplasms: a case report 56
TUMORIGENIC POTENTIAL OF CANCER STEM CELLS (CSCS) ISOLATED FROM HUMAN CHOLANGIOCARCINOMA (CCA) SUBTYPES IN CIRRHOTIC LIVER 56
RFA strongly modulates the immune system and anti-tumor immune responses in metastatic liver patients 56
Monoclonal antibodies in gynecological cancer: a critical point of view. 55
Transplantation of human fetal biliary tree stem/progenitor cells into two patients with advanced liver cirrhosis 55
Characterization of Cancer Stem Cells in Human Cholangiocarcinoma (CCA) subtypes 55
The Fas/Fas ligand apoptosis pathway underlies immunomodulatory properties of human biliary tree stem/progenitor cells. 54
Regulated expression of MUC1 epithelial antigen in erythropoiesis 54
Circulating CD137+ T cell levels are correlated with response to pembrolizumab treatment in advanced head and neck cancer patients 53
MGL lectin receptor and immunosuppression networks in glioblastoma 52
Interaction between treg cells and angiogenesis: A dark double track 52
Thinking twice before abandoning first-line chemotherapy in ovarian cancer: report of two cases and literature review. Passing from tri-weekly to weekly regimens 52
Neoantigens from the bench to the bedside. new prospective for ovarian cancer immunotherapy 52
Circulating CD137+T cells as an immune biomarker for response to anti-PD1 immunotherapy in NSCLC patients 48
Targeting of macrophage galactose-type C-type lectin (MGL) induces DC signaling and activation 46
T cell activation induced by MUC1 synthetic glycopeptides 45
Seasonal modulation of the C-type lectin MGL on human DCs 45
null 45
Tumorigenic potential of cancer stem cells (CSCs) isolated from human cholangiocarcinoma (CCA) subtypes in cirrhotic microenvironment 44
Immunologic Systemic Effect of Neoadjuvant Chemotherapy Requires Investigation Before Tumor-Associated Lymphocytes Can Be Introduced in Breast Cancer Treatment Algorithm 43
TGF-beta signaling is an effective target to block proliferation and induce apoptosis of human cholangiocarcinoma (CCA) cells: a study on human primary cell cultures 43
HER2-based recombinant immunogen to target DCs through Fc gamma Rs for cancer immunotherapy 41
Investigating patterns of immune interaction in ovarian cancer: probing the O-glycoproteome by the macrophage galactose-like C-type Lectin (MGL) 41
Macrophage galactose-like lectin mediated interactions: investigating immunosuppressive mechanisms in glioblastoma 39
Glycan-Lectin Interactions as Novel Immunosuppression Drivers in Glioblastoma 39
Immunomodulatory effects of tyrosine kinase inhibitors (TKIs) in renal cell carcinoma (RCC) patients 38
Engagement of MGL by the Tn-tumor glycoform of MUC1 induces DC signaling and activation 37
Exosome factory: a new strategy for antitumor vaccines. 36
DCs internalize and efficiently process Tn-MUC1 glycoprotein through MGL. 36
Exosomes factory: a new strategy for antitumour vaccines 36
null 33
MAGE-A and NY-ESO-1 expression in cervical cancer: investigation on prognostic factors and effect of chemotherapy 33
Sensitivity of human cholangiocarcinoma (CCA) cells and CCA cancer stem cells (CSCs) to chemotherapeutics and molecular targeted agents 31
Effects on the immune response following tumor ablation by radiofrequency. 31
MUC1 cross talk molecule during erythroid differentiation. 31
A network approach to define the predictive role of immune profile on tumor response and toxicity of anti PD-1 single agent immunotherapy in patients with solid tumors 30
Immunomodulatory effects of radiofrequency tumor ablation in liver tumor patients. 30
Immunoregulatory function of MUC1 tumor antigen during hematopoiesis 30
null 30
Exosome factory: new strategy for the production of cell-free anti-tumor vaccine. 29
Exosome factory: new strategy for the production of cell-free antitumor vaccines 29
Tumour associated MUC1 glycoform interacts with dendritic cells through Mgl 27
Soluble Immune checkpoints, gut metabolites and performance status as parameters of response to Nivolumab treatment in NSCLC patients 27
Immunomodulatory function of tumor antigen carrying vesiscles. 26
Generazione dell'immunogeno ErbB2-Fc per la vaccinazione a base di cellule dendritiche 26
Sensitivity of human intrahepatic cholangiocarcinoma subtypes to chemotherapeutics and molecular targeted agents: A study on primary cell cultures 26
Metformin reduces cell migration and down-regulates epithelial to mesenchymal transition (EMT) by AMPK/Foxo3a pathway in human intrahepatic cholangiocarcinoma (CCA) 26
null 25
Proteomic characterization of extracellular vesicles released by third stage larvae of the zoonotic parasite anisakis pegreffii (Nematoda: Anisakidae) 24
CD137+ and regulatory T cells as independent prognostic factors of survival in advanced non-oncogene addicted NSCLC patients treated with immunotherapy as first-line 24
Totale 6.202
Categoria #
all - tutte 16.471
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.471


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019366 0 0 0 0 0 0 0 0 0 0 206 160
2019/20201.329 166 42 32 53 138 181 185 153 145 128 58 48
2020/2021600 48 50 37 62 45 51 12 47 66 131 45 6
2021/20221.152 25 58 78 48 146 29 33 92 94 84 283 182
2022/20231.346 239 243 77 123 124 118 29 89 173 30 57 44
2023/2024883 44 118 40 65 132 205 33 90 13 90 53 0
Totale 6.369